Searchable abstracts of presentations at key conferences in endocrinology

ea0022p336 | Diabetes | ECE2010

Therapeutic objectives in the care of patients with diabetes mellitus type 2 in clinical practice at an endocrine department

Jimenez Carmen Tenorio , Ibarra Pablo Jose Lopez , Munoz Manuel Romero , del Valle Maria Jimenez

According to the American Diabetes Association (ADA), achieving specific treatment goals in type 2 diabetes can substantially reduce microvascular complications, including retinopathy, nephropathy and neuropathy. Intensive management has also been shown to have a beneficial effect on cardiovascular disease. The objective of the study is to evaluate the degree of achievement of appropriate target levels for A1C, as an index of chronic glycaemia, LDL-c and blood pressure, in a l...

ea0044p148 | Neuroendocrinology and pituitary | SFEBES2016

Post-traumatic amnesia, but not acute CT brain findings, predicts pituitary dysfunction following traumatic brain injury

O'Shea Triona , Feeney Claire , Zaw-Linn Joanna , Jimenez Carmen Tenorio , Han Tim , Baxter David , Sharp David , Goldstone Anthony

Pituitary dysfunction is a common, treatable consequence of traumatic brain injury (TBI), and is associated with poorer outcomes. Identifying prognostic factors that allow targeted endocrine testing will ensure that patients at higher risk of pituitary dysfunction are identified and screened.Analysis of 176 adults at least 6 weeks after TBI attending the multidisciplinary Imperial TBI clinic found an overall prevalence of pituitary dysfunction of 13.7% (...

ea0032p970 | Steroid metabolism and action | ECE2013

Screening for Cushing’s syndrome in obese patients

Exposito Maria Rosa Alhambra , Jimenez Carmen Tenorio , Sanchez Inmaculada Prior , Puerta Maria Jose Molina , Moreno Paloma Moreno , Jimenez Concepcion Munoz , Moreno Maria Angeles Galvez , Lopez Pedro Benito

Background: Cushing’s syndrome (CS) is considered to be more frequent among patients with metabolic syndrome. Previous studies have suggested to perform a routine screening for CS in obese patients; however, more recent reports only recommend a case-finding approach in patients with uncontrolled diabetes and hypertension, despite appropriate treatment.Objective: The aim of this study was to evaluate the prevalence of unsuspected CS in morbidly obese...

ea0032p1109 | Thyroid cancer | ECE2013

Predictive value of preablation stimulated thyroglobulin in differentiated thyroid cancer

Sanchez Inmaculada Prior , Moreno Ma Angeles Galvez , Jimenez Carmen Tenorio , Exposito Ma Rosa Alhambra , Ortega Raul Ruiz , Ortega Estefania Moreno , Vallejo Casas Juan Antonio , Lopez Pedro Benito

Background: Previous studies have suggested that serum thyroglobulin (Tg) levels at the time of 131I remnant ablation just after thyroidectomy, could be a prognostic tumor marker in differentiated thyroid cancer (DTC).Objective: The aim of this study was to evaluate if serum preablation Tg in the earliest postoperative period could be useful for predicting persistence or recurrence of disease.Methods: This study was a retrospective...

ea0099rc5.8 | Rapid Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Outcomes of transsphenoidal surgery for producing pituitary adenomas in spain

Paja Fano Miguel , Hanzu Felicia , Angeles Galvez Mª , Villar Rocio , Moure Dolores , Menendez Edelmiro , Gonzalez-Fernandez Laura , Egana Nerea , Camara Rosa , Penalver David , Simo Andreu , Asensio-Wandosell Diego , Tenorio Carmen , Novo Cristina , Calatayud Maria , Pico Antonio , Sottile Johana , Diaz-Soto Gonzalo , Penalver David , Araujo-Castro Marta , Soto Alfonso , De Pablos Pedro , Aulinas Anna , Munoz Fernando , Biagetti Betina

In our country, as in others, there is a lack of data on the success rate of transsphenoidal surgery for producing pituitary adenomas. We evaluated the results reported in TESSPAIN, a retrospective multicenter nationwide project that includes all the TSS performed in the participating centers in the period between 2018 and 2022, both included. Surgical treatment success is defined according to the published criteria for each disease: normal IGF-1 and GH after 75 g of oral gluc...

ea0099ep193 | Pituitary and Neuroendocrinology | ECE2024

An overview of transsphenoidal surgery in spain from 2018 to 2022

Paja Fano Miguel , Biagetti Betina , Guerrero-Perez Fernando , Camara Rosa , Moure Dolores , Hanzu Felicia , Angeles Galvez M. , Simo Andreu , Villar Rocio , Vicente Almudena , Parra Paola , Martin-Rojas Patricia , Serra Guilermo , Aulinas Anna , Munoz Fernando , Calatayud Maria , Araujo-Castro Marta , Librizzi Soledad , Irigaray Ana , Ollero Dolores , Aznar Silvia , Menendez Edelmiro , Gonzalez-Vidal Tomas , Abarca Javier , Pico Antonio , Sottile Johana , Garcia Rogelio , Gonzalez-Fernandez Laura , Delgado Ana , Ortiz Isabel , Tenorio Carmen , Novo Cristina , Recio Jose , Egana Nerea , De Pablos Pedro , Crespo Cristina , Penalver David , Diaz-Soto Gonzalo , Raventos Aina , Asensio-Wandosell Diego , Puig-Domingo Manel , Soto Alfonso

Transsphenoidal surgery (TSS) of the hypothalamic-pituitary region is the approach of choice because of its lower morbidity compared to the transcranial approach. However, its results are highly variable and depend on many factors related to the tumor itself, to the medical team, and to technical issues. We review the situation of this procedure in a nationwide retrospective multicenter evaluation. Data were collected from centers participating in the TESSPAIN (TranssphEnoidal...